Theralase Technologies Inc.
TLTFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,033 | $1,070 | $1,139 | $781 |
| % Growth | -3.4% | -6% | 45.9% | – |
| Cost of Goods Sold | $479 | $508 | $510 | $471 |
| Gross Profit | $554 | $562 | $628 | $310 |
| % Margin | 53.6% | 52.5% | 55.2% | 39.7% |
| R&D Expenses | $2,754 | $2,982 | $4,281 | $2,925 |
| G&A Expenses | $1,944 | $2,030 | $1,442 | $1,753 |
| SG&A Expenses | $2,049 | $2,127 | $1,530 | $1,850 |
| Sales & Mktg Exp. | $105 | $97 | $88 | $97 |
| Other Operating Expenses | $40 | $47 | $49 | $77 |
| Operating Expenses | $4,842 | $5,309 | $5,860 | $4,851 |
| Operating Income | -$4,288 | -$4,594 | -$5,232 | -$4,542 |
| % Margin | -415% | -429.2% | -459.5% | -581.8% |
| Other Income/Exp. Net | $32 | $23 | -$4 | $130 |
| Pre-Tax Income | -$4,256 | -$4,571 | -$5,235 | -$4,411 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4,256 | -$4,571 | -$5,235 | -$4,411 |
| % Margin | -411.8% | -427.1% | -459.8% | -565.1% |
| EPS | -0.018 | -0.021 | -0.025 | -0.022 |
| % Growth | 14.9% | 17.5% | -16.7% | – |
| EPS Diluted | -0.018 | -0.021 | -0.025 | -0.022 |
| Weighted Avg Shares Out | 240,069 | 219,968 | 207,924 | 204,276 |
| Weighted Avg Shares Out Dil | 240,069 | 219,968 | 207,924 | 204,276 |
| Supplemental Information | – | – | – | – |
| Interest Income | $66 | $50 | $31 | $23 |
| Interest Expense | $24 | $30 | $21 | $5 |
| Depreciation & Amortization | $272 | $286 | $313 | $276 |
| EBITDA | -$3,960 | -$4,254 | -$4,901 | -$4,130 |
| % Margin | -383.2% | -397.5% | -430.4% | -529% |